Now, just two years after it was founded, Cannovum is the first German medical cannabis business that is listed on the stock exchange, making the 30-year-old Pia Marten the youngest female CEO to have a company listed on a German stock exchange. Since this applies to the wholesalers, like Cannovum, as well as to the producers, the company had to choose its producer based on an extremely strict set of requirements and check compliance with all requirements on site.įortunately, this strenuous process paid off. That being said, the legal and pharmaceutical framework for the trade of medical cannabis in Germany are known to be very stringent in order to protect patients. Cannovum is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis aiming to supply patients in Germany and the rest of Europe with its own sustainable medical cannabis brand. In 2019, equipped with her experience and expertise from past ventures, she went on to found Cannovum AG together with Marius Koose, who has many years of experience in the pharmaceutical sector. So, Marten took a different approach to medical cannabis than the competition. Sustainability meets medical cannabisĪs a result of her time working in the renewable energy sector, the topic of sustainability has been with Marten for a long time. We are the first company to bring sustainably produced medicinal cannabis to Germany," said Marten in an interview with. Sustainable cultivation is very important to me. "I want to make a positive contribution, work on something meaningful For me, sustainability, future potential and quality of life are the keywords that connect medical cannabis and regenerative energies. Pia Marten, who previously worked in the renewable energy sector and gained experience in the operational management of a company, saw the potential benefits of medical cannabis and decided to act. With the public debate being hung up on recreational marijuana and legislation changing ever so slowly, a lot of potential to help patients is being left on the table. Unfortunately, this stigmatization is preventing many ill patients from receiving access to medical cannabis even though it could help them. That being said, there is still a certain stigma surrounding cannabis. Further, the medical cannabis market alone is expected to be worth around €7.7 billion by 2028. Cannovum Boersenlisting/Photograph Harald Schnauder Pia MartenĪccording to Prohibition Partners, over a million German patients will have access to medical cannabis by 2024. While this market segment is still in its infancy, its future is looking very bright. The medical cannabis market in Germany is booming and towering over other European cannabis markets, with new research and legislation paving the way for potentially immensely beneficial medical cannabis therapies. A more detailed discussion of the risks is available in the “Annual Information Form” filed by Globex on SEDAR at only is Germany at the heart of Europe, but it is also at the heart of the European cannabis landscape. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits Globex will derive therefrom. These statements may involve a number of known and unknown risks and uncertainties and other factors that may cause the actual results, level of activity and performance to be materially different from the expectations and projections of Globex Mining Enterprises Inc. Tel.: 819.797.5242 Fax: 819.797.1470 Forward Looking Statements: Except for historical information, this news release may contain certain “forward looking statements”. 86, 14 th Street Rouyn-Noranda, Quebec Canada J9X 2J1 President & CEO Globex Mining Enterprises Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |